跳至主要内容
临床试验/NCT02183948
NCT02183948已完成早期 1 期

Effect of Oxytocin on Masked Facial Expressions: an fMRI Study

University of Electronic Science and Technology of China0 个研究点目标入组 86 人开始时间: 2014年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
86
主要终点
Number of participants with neuro activity to facial expressions

研究概览

简要总结

The purpose is to test whether oxytocin has an effect on masked facial expressions

详细描述

The neuropeptide oxytocin (OXT) has been shown to modulate several aspects of human social cognition. Although the exact mechanisms behind these effects remain unclear, recent research suggests that OXT modulates the perception of cues that are important for interpersonal processing, particularly emotional facial expressions. Using a backward masking procedure and functional magnetic resonance imaging, we investigated the modulatory effects of intranasal OXT on the processing of sub-liminally presented emotional faces. In a double-blind placebo-controlled between-subject pharmaco-fMRI experiment healthy volunteers received either 24IU of intranasal oxytocin or placebo 45mins before they were presented emotional (happy, angry, fearful, sad, disgusting) faces and mirror-reversed neutral faces masked by neutral faces of the same individual. To ensure attentional processing of the faces subjects were required to perform a simple gender decision task in the scanner and a recognition memory task afterwards. All subjects were additionally assessed for their state and trait anxiety and depression as well as empathy. For the analysis, we will use matlab, SPM and SPSS to conduct structural ROI analysis and two Sample t test.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 29 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy subjects, no smoke or drink alcohol, coffee or other stimulants during the day before Experiment.

排除标准

  • history of head injury; pregnancy; uterine cavity operations were took within one year; medical or psychiatric illness; rhinitis in case they may not fully absorb the spray.

研究组 & 干预措施

Placebo

Placebo Comparator

nasal spray

干预措施: Placebo (Drug)

oxytocin

Experimental

nasal spray

干预措施: Oxytocin (Drug)

结局指标

主要结局

Number of participants with neuro activity to facial expressions

时间窗: one week

次要结局

未报告次要终点

研究者

发起方
University of Electronic Science and Technology of China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Keith Kendrick

Professor / Research group leader

University of Electronic Science and Technology of China

相似试验